For decades, gene-editing science has been limited to making small, precise edits to human DNA, akin to correcting typos in ...

Detroit Country Day School (DCDS) develops citizens and leaders of the world in a culturally diverse environment of academic ...

Daniel Passeri, Chief Executive Officer of Cue Biopharma, transitions to Strategic Advisor to provide ongoing support to the Company Cue Biopharma prioritizes autoimmune disease for next stage of ...

To help narrow things down, Sarah McKenna, Digital Content Manager at Penguin Books UK, and the Penguin editorial team turned ...

These “nonlamellar” (cubes/hexagons) structures significantly expand the potential of LNPs by providing more surface area and ...

Immunotherapy has transformed the treatment of cancer, yet many patients do not have response or lasting benefit. Strategies ...

Lewy body dementia affects more than one million people in the United States. It has two forms: Dementia with Lewy bodies and ...

As SAB initiates its Phase 2b SAFEGUARD study for SAB-142 in new-onset Stage 3 autoimmune T1D patients, EASD provided an opportunity to connect ...

Genes enriched in the phenylpropanoid biosynthesis pathway are regulated by histone modification.